ID=H0115
URL=http://www.who.int/ncd/hgn/adultes_cf.htm
SIZE=126029
DATE=11/07/2002
TIME=17:01:11
DATASET=Biology
HTML=<html>
<head>
<title>Services for adultes with cystic fibrosis</title>
<meta name="DC.title" content="Services for adultes with cystic fibrosis">

<meta name="Microsoft Border" content="none">
<meta name="DC.publisher" content="World Health Organization">
<meta name="DC.rights" content="http://www.who.int/home/copyright">
<meta name="DC.format" content="text/html">
<meta name="who.pubdate" content="Wed Jun 19 08:37:12 2002">
<meta name="who.pubby" content="kerneng@who.int">

</head>
<body topmargin="0" leftmargin="0" vlink="#008080" alink="#FF0000">
<table border="0" width="640" style="border: ">
  <tr>
    <td width="640"><table height="1" width="631">
      <tr>
        <td rowSpan="2" vAlign="top" width="120"><a href="/"><img
        alt="World Health Organization" border="0" src="../images/whologo.jpg" width="120" height="80"></a></td>
        <td vAlign="top" width="500"><a href="/"><img
        alt="World Health Organization" border="0" src="../images/top_line.gif" width="500" height="12"></a></td>
      </tr>
      <tr>
        <td vAlign="top" width="500"><p align="right"><img src="../images/hgn.gif"
        alt="hgn.gif (8550 bytes)" width="500" height="70"></td>
      </tr>
      <tr>
        <td colSpan="2" vAlign="top" width="620"><img src="../images/blue.gif"
        alt="blue.gif (943 bytes)" align="right" width="620" height="12"></td>
      </tr>
</TBODY>
    </table>
    </td>
  </tr>
  <tr>
    <td width="620"><p align="right"><font face="Arial,Helvetica,Sans Serif" size="1">Last update:18 Jun 2002</font></td>
  </tr>
  <tr>
    <td width="620"><font face="Arial,Helvetica,Sans Serif" size="1"><p align="center"></font><font size="2"><strong>|
    <a href="/m/healthtopics-a-z/en/index.html">Health topics</a> |&nbsp; <a
    href="/">WHO home</a> | <a
    href="/site-search/data-who-hq-live/search.shtml">Search</a> | <a
    href="../ncd_sitemap.htm">Site map</a> | <a href="../contact_us.htm">Contact us</a> |</strong></font></td>
  </tr>
  <tr>
    <td width="620"><hr>
    </td>
  </tr>
  <tr>
    <td width="620"><font size="2"><p align="right"><a href="/">WHO Home </a>-&gt;
    <a href="index.htm">Human genetics</a> -&gt; <a href="publications.htm">Human genetics
    publications</a> -&gt; Services for adults with cystic fibrosis<br>
    </font><br>
    </td>
  </tr>
  <tr>
    <td width="620"><div align="center"><center><table border="0" cellPadding="3"
    cellSpacing="0" width="615">
<TBODY>
      <tr>
        <td vAlign="top" width="500" height="1"><font size="2"><i>Document reference</i><span
        lang="EN-GB" style="font-size:9.0pt;mso-bidi-font-size:10.0pt">: </span></font><span
        lang="SV" style="font-size:10.0pt;font-family:"CG Times";font-variant:normal">WHO/ICF(M)A/IACFA/99.6,
        Distr.: General, </span><span lang="SV" style="font-size:10.0pt">English Only</span><p>&nbsp;</p>
        <p align="center"><strong>&nbsp;<font size="3" color="#8000FF">&nbsp;&nbsp;</font><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Arial;mso-bidi-font-family:"Times New Roman";font-variant:
small-caps"><font-size="3">Services
        for adults with cystic fibrosis</span></strong></p>
        <p class="MsoHeading9" align="center"><font face="Arial Black"><em><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times" font-style:normal">Report
        of a joint WHO/ICF(M)A/IACFA meeting<o:p></span></em></font></p>
        <i style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"CG Times"mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:"Times New Roman" mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA; layout-grid-mode:line"><b
        style="mso-bidi-font-weight:normal"><p align="center"></b><u>The Hague, The Netherlands,
        7-8 June 1999</u></span></i></td>
        <td vAlign="top" width="146" height="1" bgcolor="#eaeaf2"><table>
          <tr>
            <th bgColor="#000080"><font face="Arial,Helvetica,Sans Serif" size="2" color="#FFFF00"><strong>Human genetics
            shortcut</strong></font></th>
          </tr>
          <tr>
            <td><a href="hgn_news.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>News</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="publications.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Publications</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="databases.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Databases</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="hgn_events.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Events</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="country_profiles.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Country
            profiles</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="glopartners.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Global
            partners</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="collcentres.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Collaborating
            centres</em></strong></font></a></td>
          </tr>
          <tr>
            <td><a href="relatedsites.htm"><font face="Arial,Helvetica,Sans Serif" size="2" color="#0000FF"><strong><em>Related
            sites</em></strong></font></a></td>
          </tr>
        </table>
        </td>
      </tr>
      <tr>
        <td colSpan="2" vAlign="top" width="654" height="1"><table border="0" width="100%">
          <tr>
            <td width="100%"><table border="1" cellspacing="0" cellpadding="0"
            style="margin-left:-1.7pt;
 border-collapse:collapse;mso-table-layout-alt:fixed;mso-padding-alt:0cm 5.4pt 0cm 5.4pt"
            width="593" bordercolor="#008080" bordercolorlight="#008080" bordercolordark="#008080">
              <tr>
                <td width="300" valign="top" style="width:240.95pt;padding:0cm 5.4pt 0cm 5.4pt"
                align="center" bordercolor="#008080" bordercolorlight="#008080" bordercolordark="#008080"><p
                class="MsoNormal" style="margin-top:4.5pt;mso-hyphenate:none;tab-stops:-36.0pt"><!--[if supportFields]><span
  lang=EN-GB><span style='mso-element:field-begin'></span>PRIVATE </span><![endif]--><!--[if supportFields]><span
  lang=EN-GB><span style='mso-element:field-end'></span></span><![endif]--><span
                lang="EN-GB" style="font-size:8.0pt;mso-bidi-font-size:10.0pt">This document is not a
                formal publication of the World Health Organization (WHO), and all rights are reserved by
                the Organization.<span style="mso-spacerun: yes">&nbsp; </span>The document may, however,
                be freely reviewed, abstracted, reproduced and translated, in part or in whole, but not
                for sale nor for use in conjunction with commercial purposes.<o:p></o:p>&nbsp;<o:p></o:p></span></p>
                <p class="MsoNormal" style="margin-bottom:2.7pt;mso-hyphenate:none;tab-stops:
  -36.0pt"><span
                lang="EN-GB" style="font-size:8.0pt;mso-bidi-font-size:10.0pt">The views expressed in
                documents by named authors are solely the responsibility of those authors.<o:p></o:p></span></td>
                <td width="300" valign="top" style="width:240.95pt;padding:0cm 5.4pt 0cm 5.4pt"
                align="center"><p class="MsoNormal"
                style="margin-top:4.5pt;mso-hyphenate:none;tab-stops:-36.0pt"><span lang="FR"
                style="font-size:8.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:
  FR">Ce document
                n'est pas une publication officielle de l'Organisation mondiale de la Santé (OMS) et tous
                les droits y afférents sont réservés par l'Organisation.<span style="mso-spacerun: yes">&nbsp;
                </span>S'il peut être commenté, résumé, reproduit ou traduit, partiellement ou en
                totalité, il ne saurait cependant l'être pour la vente ou à des fins commerciales.<o:p></o:p></span></p>
                <p class="MsoNormal" style="margin-bottom:2.7pt;mso-hyphenate:none;tab-stops:
  -36.0pt"><span
                lang="FR" style="font-size:8.0pt;mso-bidi-font-size:10.0pt;
  mso-ansi-language:FR">Les
                opinions exprimées dans les documents par des auteurs cités nommément n'engagent que
                lesdits auteurs.<o:p></o:p></span></td>
              </tr>
            </table>
            </td>
          </tr>
        </table>
        <h1><span lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:10.0pt">Table of
        contents<o:p></o:p></span></h1>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><!--[if supportFields]><span
lang=EN-US><span style='mso-element:field-begin'></span><span
style="mso-spacerun: yes"> </span>TOC \o "1-3" <span
style='mso-element:field-separator'></span></span><![endif]--><span lang="EN-US">1.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#1. &nbsp; Background">Background</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">2.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#2.&nbsp; Size of problem">Size of
        problem</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">3.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#3. &nbsp; Transition">Transition</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">4.<span
        style="mso-spacerun: yes">&nbsp; </span><a
        href="#4. &nbsp; Components of adult cf service">Components of adult cf service</a></span></p>
        <blockquote>
          <p class="MsoToc3" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">4.1 <a
          href="#4.1 Multidisciplinary care">Multidisciplinary care</a><br>
          4.2 <a href="#4.2 Adult medical problems">Adult medical problems</a><br>
          4.3 <a href="#4.3 Psychosocial problems">Psychosocial problems</a></span><br>
          <span lang="EN-US">4.4 <a href="#4.4 Core CF team">Core CF team</a></span><br>
          <span lang="EN-US">4.5 <a href="#4.5 Consultants">Consultants</a></span><br>
          <span lang="EN-US">4.6 <a href="#4.6 Facilities">Facilities</a></span></p>
        </blockquote>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">5.<span
        style="mso-spacerun: yes">&nbsp; </span><a
        href="#5. &nbsp; Patterns of health care delivery">Patterns of health care delivery</a></span></p>
        <blockquote>
          <p class="MsoToc3" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">5.1 <a
          href="#5.1 Established adult CF clinics">Established adult CF clinics</a></span><br>
          <span lang="EN-US">5.2 <a href="#5.2 Parents and partners">Parents and partners</a></span><br>
          <span lang="EN-US">5.3 <a href="#5.3 Independent adult CF clinics">Independent adult CF
          clinics</a></span><br>
          <span lang="EN-US">5.4 <a href="#5.4 Other models">Other models</a></span><br>
          <span lang="EN-US">5.5 <a href="#5.5 Home care and self management">Home care and self
          management</a></span></p>
        </blockquote>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">6.<span
        style="mso-spacerun: yes">&nbsp;<a href="#6. &nbsp; The adult with CF in society"> </span>The
        adult with cf in society</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">7.<span
        style="mso-spacerun: yes">&nbsp; </span><a
        href="#7. &nbsp; Training of adult cf physicians">Training of adult cf physicians</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">8.<span
        style="mso-spacerun: yes">&nbsp;<a href="#8. &nbsp; Economics"> </span>Economics</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">9.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#9.&nbsp; Recommendations">Recommendations</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">10.<span
        style="mso-spacerun: yes">&nbsp; </span><a href="#10.&nbsp; List of participants">List of
        participants</a></span></p>
        <p class="MsoToc1" style="tab-stops:right dotted 453.0pt"><span lang="EN-US">11. <a
        href="#11. References">References</a></span></p>
        <p class="MsoNormal"><!--[if supportFields]><span lang=EN-US><span
style='mso-element:field-end'></span></span><![endif]--><span lang="EN-US">&nbsp;<o:p></o:p></span></p>
        <p class="MsoNormal"><b style="mso-bidi-font-weight:normal"><span lang="EN-US"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-font-kerning:14.0pt;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA"><span
        lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">EXECUTIVE<span
        style="mso-spacerun:
yes">&nbsp; </span>SUMMARY<o:p></o:p></span></span></b></p>
        <b style="mso-bidi-font-weight:normal"><span lang="EN-US"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-fareast-font-family:
"Times New Roman";mso-font-kerning:14.0pt;mso-ansi-language:EN-US;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA"><p
        class="MsoTitle"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">&nbsp;<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Cystic
        Fibrosis (CF) is the most common life-threatening single gene inherited disorder in people
        of European descent worldwide. Increasingly, cases are identified in other Caucasians in
        the Middle East and on the Indian subcontinent.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Until
        recently, CF has been regarded as a children's disease because few patients survived into
        adult life.<span style="mso-spacerun: yes">&nbsp; </span>However, better prevention and
        management of its complications, particularly chronic lung disease, has led to longer
        survival. Thus, in some industrialised countries, there are as many affected adults as CF
        children;<span style="mso-spacerun: yes">&nbsp; </span>and the proportion of CF children
        surviving to become adults is rapidly increasing throughout the world.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Provision
        of services for CF adults has not kept pace with this improved prognosis.<span
        style="mso-spacerun: yes">&nbsp; </span>Many adult pulmonologists have neither the
        necessary training to manage this complex disease, nor, individually, do they have enough
        patients to encourage them to develop a special interest in CF and ensure provision of the
        range of services patients need. Some CF-related conditions are specific to affected
        adults (e.g. fertility problems) while others (e.g. diabetes) may affect children but
        become more frequent and severe as the disease progresses. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">WHO,
        the International CF (Mucoviscidosis) Association ICF(M)A and the (patients')
        International Adult CF Association (IACFA) therefore convened a joint meeting (The Hague,
        7-8 June 1999) to produce recommendations for the provision of adult medical and
        associated services for CF adults. The group did not consider or make detailed clinical
        recommendations;<span style="mso-spacerun: yes">&nbsp; </span>because these
        recommendations would soon become dated and can be found in specialist textbooks and
        journals. Instead, its scope was limited to service provision. This report provides a
        reference for health care providers by outlining the range and types of specialist
        services required by CF adults, in the hope that the momentum of the improving prognosis
        can be maintained or accelerated. It includes a checklist of adult medical, psychological
        and social problems associated with CF, the composition of the specialist team, physical
        accommodation and facilities, recommended arrangements for transitional, community and
        terminal care, training of CF specialists and funding arrangements.<span
        style="mso-spacerun: yes">&nbsp; </span>It reflects the experience of the professionals
        and patients who comprised the working party.<o:p></o:p></span></p>
        <p><br clear="all" style="page-break-before:always">
        </span></b></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255524"></a><a
        name="_Toc494256037"></a><a name="_Toc494600620"></a><a name="1. &nbsp; Background"><span
        style="mso-bookmark:_Toc494600620"><span style="mso-bookmark:_Toc494256037"><span
        style="mso-bookmark:_Toc494255524"><span lang="EN-US"
        style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">1.<span style="mso-spacerun: yes">
        &nbsp; </span>Background</span></span></span></span></a><span lang="EN-US"
        style="font-size:16.0pt;mso-bidi-font-size:10.0pt"><o:p></o:p></span></h1>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Previous
        joint meetings between World Health Organization (WHO) Human Genetics Programme and the
        International Cystic Fibrosis (Mucoviscoidosis) Association (ICF(M)A) have addressed the
        need for education concerning diagnosis and management of cystic fibrosis (CF) [1-3].<sup><o:p></o:p></sup></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Cystic
        fibrosis is a genetic disease with significant variations in incidence, morbidity and
        mortality around the world. Although most often reported in white Caucasians, since
        discovery of the mutated gene in 1989 [4] it is also being diagnosed with increasing
        frequency in other populations, often with variant clinical expression. Better
        understanding and treatment of CF has led to an improved survival in countries where CF
        services are well developed [5-8]. Published data from these countries report a similar
        mean life expectancy of greater than thirty years, compared with survival less than a
        decade 30 years ago [9]. Today many CF patients reach adult life with the consequent need
        for specialist care different from pediatrics. For example in the United Kingdom it was
        calculated that at the turn of the century there would be as many adults as children with
        CF [4].<span style="mso-spacerun: yes">&nbsp;&nbsp; </span><o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        major cause of morbidity and mortality is chronic respiratory disease, but CF is a
        complicated disease affecting multiple organs which therefore requires the involvement of
        a variety of medical and other specialists. Optimal care for CF consequently needs a team
        approach which can only be coordinated in specialist centres. Such centres have developed
        in many countries and the benefits of centre care have been clearly demonstrated [8],
        although differences in survival between individual centres have also been observed [10].
        Because CF has historically been regarded as a children's disease, CF centres have
        grown up in the context of pediatric hospitals which in many instances have continued to
        provide care into adult life. However many countries have strict regulations or customs
        for transfer of patients to adult medicine at a defined age, which has highlighted the
        need for adult CF services. Health care providers and the medical profession have not
        always kept pace with the demographic changes in the disease, and may benefit from
        guidance on the development of adult CF services.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">WHO
        Human Genetics Programme, ICF(M)A and IACFA have convened this joint meeting to make
        recommendations for services for adults with CF around the world.<o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255525"></a><a
        name="_Toc494256038"></a><a name="_Toc494600621"></a><span lang="EN-US"
        style="font-size:16.0pt;
mso-bidi-font-size:10.0pt"><a name="2.&nbsp; Size of problem"><span
        style="mso-bookmark:_Toc494600621"><span style="mso-bookmark:_Toc494256038"><span
        style="mso-bookmark:_Toc494255525">2.<span style="mso-spacerun: yes">&nbsp; </span>Size of
        problem</span></span></span></a><o:p></o:p></span></h1>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">With
        continually improving survival reported from industrialized countries, there are now many
        adults with this disease. In Scandinavia for example, over 45 % of the patients are over
        18 years of age [7].<span style="mso-spacerun: yes">&nbsp; </span>This demographic change
        requires services appropriate for an adult CF population. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        requirement for separate services for CF adults will depend upon patient numbers, and will
        vary between and within countries according to the expertise and resources available.
        There is a training requirement for adult physicians interested in this disease and
        willing to devote their time and energy to providing these services.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Because
        CF is a progressive disease, it follows that a disproportionate number of adults will be
        at the severe end of the clinical spectrum. Thus, adult CF services can be anticipated to
        be relatively more expensive than their pediatric counterparts. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">In
        some countries and cities it may be appropriate to provide pediatric and adult care at the
        same centre; but it even so it is necessary to provide specific services for adults for
        which there is no pediatric equivalent. It is recommended that an adult CF clinic should
        be established when numbers of adults in a centre are 50 or above. <o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255526"></a><a
        name="_Toc494256039"></a><a name="_Toc494600622"></a><a name="3. &nbsp; Transition"><span
        style="mso-bookmark:_Toc494600622"><span style="mso-bookmark:_Toc494256039"><span
        style="mso-bookmark:_Toc494255526"><span lang="EN-US"
        style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">3.<span style="mso-spacerun: yes">
        &nbsp; </span>Transition</span></span></span></span></a><span lang="EN-US"
        style="font-size:16.0pt;mso-bidi-font-size:10.0pt"><o:p></o:p></span></h1>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">Adolescents
        and young adults with chronic conditions share the same developmental, social, and
        emotional needs as their healthy peers. There are multiple transitions that the young
        healthy adult has to go through: family home to independent living, romantic partnership
        and education for a career. All these transitions help the person to become increasingly
        self-sufficient.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">In
        addition, persons with a chronic disease need to make a transition within the health care
        system to gain greater personal responsibility for their illness. </span><span
        lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman"">Improving
        the sense of control in the CF child, by giving children time alone with the specialist,
        should be introduced from an early age.<span style="color:black"><o:p></o:p></span></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">Problems
        arise in transition because there may be limited access to adult caregivers due to lack of
        training and funding. There is no model which is proven superior to others, however the
        physiological and psychological development from a child into an adult must be taken
        seriously.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-fareast-language:SV;layout-grid-mode:
line">If
        a combined clinic is more appropriate to the national culture, population size or
        resources, access and possible transfers to other doctors in the same clinic should be
        available once adulthood has been reached. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-fareast-language:SV;layout-grid-mode:
line">It
        is essential to treat each adolescent as an individual and to retain flexibility in the
        age at which transfer is arranged according to the physical and emotional development of
        the patient. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-fareast-language:SV;layout-grid-mode:
line">It
        is also helpful if the adult specialist is present in certain pediatric clinic sessions so
        that transfer does not imply a total break from the familiar services.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-fareast-language:SV;layout-grid-mode:
line">Occasionally
        the diagnosis of CF is delayed until teenage or adult life. These patients may find it
        more difficult to adjust to the diagnosis and its implications than those diagnosed in
        childhood.<span style="mso-spacerun:
yes">&nbsp; </span><o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255527"></a><a
        name="_Toc494256040"></a><a name="_Toc494600623"></a><a
        name="4. &nbsp; Components of adult cf service"><span style="mso-bookmark:_Toc494600623"><span
        style="mso-bookmark:_Toc494256040"><span style="mso-bookmark:_Toc494255527"><span
        lang="EN-US" style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">4.<span
        style="mso-spacerun: yes"> &nbsp; </span>Components of adult cf service</span></span></span></span></a><span
        lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:10.0pt"><o:p></o:p></span></h1>
        <h3><a name="_Toc494255528"></a><a name="_Toc494256041"></a><a name="_Toc494600624"></a><a
        name="4.1 Multidisciplinary care"><span style="mso-bookmark:
_Toc494600624"><span
        style="mso-bookmark:_Toc494256041"><span style="mso-bookmark:
_Toc494255528"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">4.1
        Multidisciplinary care</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        care for adult CF patients must be multidisciplinary since the disease affects the whole
        body. It also has major psychological and social consequences for the individual. Older
        patients with CF are striving for independence, control of their situation and major input
        into health management decisions. Expectations are high because they have become
        accustomed to a high standard of pediatric care with individual attention.<o:p></o:p></span></p>
        <h3><a name="_Toc494255529"></a><a name="_Toc494256042"></a><a name="_Toc494600625"></a><a
        name="4.2 Adult medical problems"><span style="mso-bookmark:
_Toc494600625"><span
        style="mso-bookmark:_Toc494256042"><span style="mso-bookmark:
_Toc494255529"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">4.2
        Adult medical problems</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">New
        medical issues might arise for the CF patient in adult life. Most of these can also affect
        children, but occur with greater frequency as they become older. These include: <o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l14 level1 lfo58;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">increased frequency of
        respiratory exacerbations;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">emergence of new
        pathogens;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">haemoptysis;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">pneumothorax;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">allergic bronchpulmonary
        aspergillosis;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">cardiac failure;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">respiratory failure;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">malnutrition;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">distal intestinal
        obstruction syndrome (DIOS/meconium ileus equivalent);<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">gallstones;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">pancreatitis;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">malignancy of the
        gastrointestinal tract;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">progressive liver
        disease;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">portal hypertension and
        oesophageal varices;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">diabetes mellitus;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">nasal polyposis and
        sinusitis;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">osteoporosis;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">arthropathy;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">vasculitis;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">male infertility;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l21 level1 lfo45;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">pregnancy;<o:p></o:p></span></p>
        <p class="ListBulletm"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l17 level1 lfo46;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">pre/post lung
        transplantation.<o:p></o:p></span></p>
        <h3><a name="_Toc494255530"></a><a name="_Toc494256043"></a><a name="_Toc494600626"></a><a
        name="4.3 Psychosocial problems"><span style="mso-bookmark:
_Toc494600626"><span
        style="mso-bookmark:_Toc494256043"><span style="mso-bookmark:
_Toc494255530"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">4.3
        Psychosocial problems</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        transfer of responsibility from the parents to the CF individual involves both
        psychological and social adjustments (see Section 7).<o:p></o:p></span></p>
        <h3><a name="_Toc494255531"></a><a name="_Toc494256044"></a><a name="_Toc494600627"></a><a
        name="4.4 Core CF team"><span style="mso-bookmark:
_Toc494600627"><span
        style="mso-bookmark:_Toc494256044"><span style="mso-bookmark:
_Toc494255531"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">4.4
        Core CF team</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        following personnel are required as core members of the CF team:<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l24 level1 lfo47;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Respiratory physician
        and medical team;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l24 level1 lfo47;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Clinical Nurse
        Specialist and home care nurse if appropriate (see 5.5);<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l24 level1 lfo47;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Specialist
        physiotherapist/respiratory therapist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l24 level1 lfo47;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Specialist dietitian;<o:p></o:p></span></p>
        <p class="ListBulletm"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l26 level1 lfo59;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Social worker.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black;layout-grid-mode:line">Although
        not part of the core CF team, other health care providers such as </span><span
        lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
layout-grid-mode:line">general
        practitioners and university, college or occupational health services may contribute to
        the care of individuals with CF and appropriate liaison arrangements should be made.<o:p></o:p></span></p>
        <h3><a name="_Toc494255532"></a><a name="_Toc494256045"></a><a name="4.5 Consultants"><span
        style="mso-bookmark:_Toc494256045"><span style="mso-bookmark:_Toc494255532"><span
        lang="EN-US"
        style="font-size:14.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";font-weight:normal">4.5
        </span><span style="mso-bookmark:_Toc494605323"><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal">Consultants</span></span></span></span></a><span
        lang="EN-US"
        style="font-size:
14.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";font-weight:
normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        skills of the following specialists will also be needed:<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Expert laboratory
        support services: microbiology, biochemistry, immunology, pathology, genetics;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Pharmacist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Gastroenterologist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">General surgeon;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Thoracic surgeon;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Radiologist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Endocrinologist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Otorhinolaryngologist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Anaesthetist/Intensive
        care specialist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Infectious disease
        specialist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Psychologist with
        psychiatric support;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Obstetrician/gynecologist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Rheumatologist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Transplant services
        team;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Geneticist;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Pain relief team;<o:p></o:p></span></p>
        <p class="ListBulletm"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l23 level1 lfo48;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Terminal care team
        including chaplain/religious advisor where appropriate.<o:p></o:p></span></p>
        <h3><a name="_Toc494255533"></a><a name="_Toc494256046"></a><a name="_Toc494600628"></a><a
        name="4.6 Facilities"><span style="mso-bookmark:
_Toc494600628"><span
        style="mso-bookmark:_Toc494256046"><span style="mso-bookmark:
_Toc494255533"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">4.6
        Facilities</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Provision
        of a comprehensive CF service requires extensive organisational arrangements. These
        include:<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Inpatient accommodation;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Outpatient
        accommodation;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Lung function testing
        with facilities to prevent cross-infection between patients;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Facilities for isolating
        patients with transmissible organisms such as <i style="mso-bidi-font-style:normal">Burkholderia
        cepacia</i> and methicillin-resistant <i style="mso-bidi-font-style:normal">Staphylococci
        (MRSA)</i>;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Home care services;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Shared care arrangements
        at outlying hospitals where appropriate;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l8 level1 lfo49;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Liaison with pediatric
        clinic including transition arrangements.<o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255534"></a><a
        name="_Toc494256047"></a><a name="_Toc494600629"></a><a
        name="5. &nbsp; Patterns of health care delivery"><span style="mso-bookmark:_Toc494600629"><span
        style="mso-bookmark:_Toc494256047"><span style="mso-bookmark:_Toc494255534"><span
        lang="EN-US" style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">5.<span
        style="mso-spacerun: yes"> &nbsp; </span>Patterns of health care</span><span lang="EN-US">
        </span><span style="mso-bookmark:_Toc494605325"><span lang="EN-US"
        style="font-size:16.0pt;mso-bidi-font-size:10.0pt">delivery</span></span></span></span></span></a></h1>
        <h3><a name="_Toc494255535"></a><a name="_Toc494256048"></a><a name="_Toc494600630"></a><a
        name="5.1 Established adult CF clinics"><span style="mso-bookmark:
_Toc494600630"><span
        style="mso-bookmark:_Toc494256048"><span style="mso-bookmark:
_Toc494255535"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">5.1
        Established adult CF clinics</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Independent
        adult Cystic Fibrosis Clinics have been established for the past 20-30 years in some
        countries. At these centres, all inpatient and outpatient care is provided by a
        multidisciplinary team similar to that described above. <o:p></o:p></span></p>
        <h3><a name="_Toc494255536"></a><a name="_Toc494256049"></a><a name="_Toc494600631"></a><a
        name="5.2 Parents and partners"><span style="mso-bookmark:
_Toc494600631"><span
        style="mso-bookmark:_Toc494256049"><span style="mso-bookmark:
_Toc494255536"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">5.2
        Parents and partners</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">In
        an Adult CF Clinic, patients are encouraged to take more responsibility for their own
        medical care. Parents should normally not be completely excluded (if only because with
        advancing disease the patient may revert to a greater degree of dependence), but patients
        in an adult clinic need the opportunity to be seen independently. This facilitates frank
        and open discussion about relationships, contraception, adherence to therapy, possible
        alcohol or substance abuse and other concerns. The family will continue to have a major
        role as supporters and advocates, and in many cases adult patients involve life partners
        in their health management.<o:p></o:p></span></p>
        <h3><a name="_Toc494255537"></a><a name="_Toc494256050"></a><a name="_Toc494600632"></a><a
        name="5.3 Independent adult CF clinics"><span style="mso-bookmark:
_Toc494600632"><span
        style="mso-bookmark:_Toc494256050"><span style="mso-bookmark:
_Toc494255537"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">5.3
        Independent adult CF clinics</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Wherever
        there are sufficient adult patients and adequate resources a specialized adult clinic
        would seem to be the preferred model.<b style="mso-bidi-font-weight:normal"> An adult
        physician and team that is both interested and capable of providing good quality care is
        fundamental to such a model. Motivation, commitment and dedication of time by the team are
        more important than any other consideration.<span style="mso-spacerun: yes">&nbsp; </span>If
        these conditions cannot be met no attempt should be made to establish an independent
        clinic. </b>Appropriate professional training of all members of the adult
        multidisciplinary team is required. <o:p></o:p></span></p>
        <h3><a name="_Toc494255538"></a><a name="_Toc494256051"></a><a name="_Toc494600633"></a><a
        name="5.4 Other models"><span style="mso-bookmark:
_Toc494600633"><span
        style="mso-bookmark:_Toc494256051"><span style="mso-bookmark:
_Toc494255538"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">5.4
        Other models</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">There
        are a variety of models of adult care ranging from an adult physician attending the
        pediatric clinic through to the provision of a full and comprehensive service being
        provided by an independent adult team. The appropriate model for each clinic will depend
        on numbers of adult patients, availability of skilled adult team members and the provision
        of adequate resources (financial, infrastructure, allocated time). If there are no
        adequately trained and motivated personnel to provide an adult CF team, the pediatric CF
        clinic will need to develop its services and facilities to cope with the needs of adults.
        This has certain advantages, in respect of continuity of care and the expert knowledge and
        experience of the pediatric CF team, but may be perceived by adult patients as continuing
        a parental relationship and diminishing their autonomy.<o:p></o:p></span></p>
        <h3><a name="_Toc494255539"></a><a name="_Toc494256052"></a><a name="_Toc494600634"></a><a
        name="5.5 Home care and self management"><span style="mso-bookmark:
_Toc494600634"><span
        style="mso-bookmark:_Toc494256052"><span style="mso-bookmark:
_Toc494255539"><span
        lang="EN-US" style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-weight:normal">5.5
        Home care and self management</span></span></span></span></a><span lang="EN-US"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-weight:normal"><o:p></o:p></span></h3>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">Home
        care consists of any type of therapy provided in the home that attempts to prevent or
        reduce secondary complications of CF.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">Components
        of home treatment involve: intravenous antibiotics, intensified physiotherapy and
        nutritional support. In addition, psychosocial support should be offered in the home
        setting.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">The
        evolution of home care options as alternatives for traditional hospital based care
        highlights increased expertise and expectations of progress in CF treatment. Benefits and
        risks must be weighed carefully before home treatment can be advised and instituted. There
        are considerable differences in uptake of home care programmes between CF-care centers
        which may also be influenced by national health care provision systems including
        reimbursement for home care costs. Aspects of legal responsibility for care and care
        complications may arise in those under age or in those with severe advanced disease.<b
        style="mso-bidi-font-weight:
normal"><o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">The
        <b style="mso-bidi-font-weight:
normal">advantage</b> of home care is that it leads to
        less interruption of regular life. Home treatment might also reduce the risk of cross
        infection between CF patients, and it decreases the financial burden for the patient and
        the community since a hospital bed is not needed. Many consider maintenance of individual
        independence the most important factor offered in home care, and patients may be less
        inclined to minimize symptoms if they know that intervention does not necessarily involve
        admission to hospital.<span style="mso-spacerun: yes">&nbsp; </span>However, few data
        exist on true cost effectiveness or cost utility.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";color:black">The
        <b style="mso-bidi-font-weight:
normal">disadvantage</b> of home care is that medical
        treatment is less controlled. Physiotherapy and nutritional support may be less consistent
        and intensive. Furthermore, the family continues to carry the burden of CF when the
        patient is sick, which may lead to increased psychological stress. <o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l11 level1 lfo50;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">Conditions for home
        care;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l11 level1 lfo50;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">adequate facilities in
        the home;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l11 level1 lfo50;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">adequate teaching of
        patient and family;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l11 level1 lfo50;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">adequate physical and
        psychological strength of care givers; <o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l11 level1 lfo50;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">medical suitability of
        patient;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l11 level1 lfo50;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">regular home
        surveillance/guidance from the CF center;<o:p></o:p></span></p>
        <p class="ListBulletm"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l10 level1 lfo51;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">availability of
        community doctor/nurse specialist in case of emergency.<o:p></o:p></span></p>
        <p class="MsoNormal"><b style="mso-bidi-font-weight:normal"><u><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
color:black">It
        must be clearly stressed that home care is not an ideal choice for all patients and
        careful advice and assessment is needed.</span></u><span lang="EN-US"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";color:black">
<o:p></o:p>        </span></b></p>
        <p class="MsoNormal"><b style="mso-bidi-font-weight:normal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
color:black">Terminal
        care</span></b><span lang="EN-US"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";color:black">
        of the dying patient at home will depend on local settings. If attempted, psychological
        strength of caregivers must be ensured and medical and nursing support systems must be
        available. <o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255540"></a><a
        name="_Toc494256053"></a><a name="_Toc494600635"></a><a
        name="6. &nbsp; The adult with CF in society"><span style="mso-bookmark:_Toc494600635"><span
        style="mso-bookmark:_Toc494256053"><span style="mso-bookmark:_Toc494255540"><span
        lang="EN-US" style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">6.<span
        style="mso-spacerun: yes"> &nbsp; </span>The adult with CF in society</span></span></span></span></a><span
        lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:10.0pt"><o:p></o:p></span></h1>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        adult CF subject desires as normal a life as possible.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Occasional
        patients are not diagnosed before adulthood. These patients may experience a period of
        psychological adjustment with similar responses (e.g. emotional shock, denial, relief,
        anger guilt depression etc.) to those which are more usually encountered in the parents of
        a newly diagnosed child, and these reactions need to be recognized and accommodated by
        caregivers.<o:p></o:p></span></p>
        <p><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:
"Times New Roman";mso-fareast-font-family:"Times New Roman";mso-ansi-language:
EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA">&nbsp;</p>
        <p><br clear="all" style="page-break-before:always">
        </span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman""><b
        style="mso-bidi-font-weight:normal">Psychological characteristics of CF adults may include
        the following</b>:<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Many
        adults with CF are dissatisfied with their physical appearance and feel unattractive.
        Emotional disturbances are mainly presented in the form of anxiety and depression. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Normal
        peer relations can be difficult and CF subjects have often met together. Recent trends
        have reduced this possibility, especially in CF centres that have instituted segregated
        care for CF patients. CF camps for children and adolescents have been withdrawn due to the
        risk of crossinfection. Patients may thus become socially isolated. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">There
        may be a delay in achieving independence from parents with regard to both separate living
        and financial support. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Children
        with CF may have missed significant periods of school, sometimes through overprotection,
        and higher education may not have been contemplated. Impaired health during adolescence
        and adult life makes sedentary occupations more appropriate than manual work, but patients
        often have difficulty in obtaining suitable training. Attendance at universities and
        colleges away from home may involve transfer to a new and unfamiliar clinic, and requires
        a degree of emotional independence which some may not have achieved.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Adults
        with CF may have difficulty finding a partner and are often reluctant to reveal their
        illness to others. There is therefore a significantly smaller proportion of CF adults
        married or cohabiting than in the normal healthy population. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Adults
        with CF may become biological parents with the help of modern reproductive technology.
        This raises new ethical, emotional and medical issues for both patients and caregivers.
        Before considering pregnancy, it is essential that the subject is discussed in depth with
        the couple in the best interest of themselves and the potential child.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">CF
        adults are less likely to be in paid employment, the reason appearing to be predominantly
        health related. Daily activities, such as looking after the home or pursuing a hobby may
        also be impaired due to ill health.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Psychosocial
        support is needed to help CF adults to face the challenges of all these problems, and is
        an indispensible component of the service provision.<span
        style="color:black;layout-grid-mode:
line"> However, it must be stressed that the
        majority of CF adults are psychologically stable and well-adjusted, even in the presence
        of advanced disease.</span><o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">All
        team members, but most importantly the physicians, must be trained to understand these
        worries and struggles, so that they may help and encourage the patients and families to
        attend to them and not to be embarrassed by the team's awareness of their existence.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Dealing
        with end of life issues still remains an extremely important psychosocial issue for
        patients, family members, and team members alike. It must be recognized that giving care
        to chronic sick and terminally ill patients is psychologically demanding, and an important
        function of the CF psychologist is to counsel and support other members of the team.<span
        style="mso-spacerun: yes">&nbsp;&nbsp;&nbsp;&nbsp; </span><o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255541"></a><a
        name="_Toc494256054"></a><a name="_Toc494600636"></a><a
        name="7. &nbsp; Training of adult cf physicians"><span style="mso-bookmark:_Toc494600636"><span
        style="mso-bookmark:_Toc494256054"><span style="mso-bookmark:_Toc494255541"><span
        lang="EN-US" style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">7.<span
        style="mso-spacerun: yes"> &nbsp; </span>Training of adult cf physicians</span></span></span></span></a><span
        lang="EN-US" style="font-size:16.0pt;mso-bidi-font-size:10.0pt"><o:p></o:p></span></h1>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Training
        will depend on the specialty from which the trainee is coming, and will depend on the
        individual's previous level of involvement with CF adults. Although trainees may
        recruited from respiratory medicine, general internal medicine, infectious disease,
        gastroenterology and immunology, the majority will be trainee pulmonologists.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        basic training of pulmonologists differs between countries. Consequently this leads to a
        difference in knowledge of internal medicine. Therefore programmes to train pulmonologists
        in CF specialised care need to be tailored with respect to the educational background of
        pulmonologists in each country. With increasing age, other CF-related non-pulmonary
        complications like exocrine pancreatic insufficiency, diabetes, hepatobiliary disease,
        distal intestinal obstruction and musculo-skeletal disorders will contribute significantly
        to morbidity and require specialised care. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Although
        there are no definite models for physicians wishing to train to be centre directors in
        cystic fibrosis units, relatively informal arrangements are available in Europe, North
        America and Australia usually involving a 2-year period spent as a trainee in an Adult CF
        Unit. <o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">The
        following areas should be considered for training: <o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">general internal
        medicine, respiratory medicine and gastroenterology;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">management of diabetes
        and nutrition;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">attachment to a
        pediatric CF unit for a period of time;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">trainees should have
        appropriate understanding of laboratory support services;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">involved in the CF care,
        particularly in medical genetics and microbiology;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">understanding the role
        of clinical psychology;<o:p></o:p></span></p>
        <p class="ListBulletmr"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l27 level1 lfo53;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">a period of at least 2
        months should be spent in a transplantation centre;<o:p></o:p></span></p>
        <p class="ListBulletm"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:
l34 level1 lfo54;tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:Symbol">·<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-US" style="font-size:12.0pt;mso-bidi-font-size:
10.0pt">performing or
        coordinating a research project.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">For
        other core CF team members a period of attachment to an established CF center elsewhere is
        highly desirable before taking up their appointment. <o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255542"></a><a
        name="_Toc494256055"></a><a name="_Toc494600637"></a><a name="8. &nbsp; Economics"><span
        style="mso-bookmark:_Toc494600637"><span style="mso-bookmark:_Toc494256055"><span
        style="mso-bookmark:_Toc494255542"><span lang="EN-US"
        style="font-size:16.0pt;
mso-bidi-font-size:10.0pt">8.<span style="mso-spacerun: yes">
        &nbsp; </span>Economics</span></span></span></span></a><span lang="EN-US"
        style="font-size:16.0pt;mso-bidi-font-size:10.0pt"> <o:p></o:p></span></h1>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman""><b
        style="mso-bidi-font-weight:normal">Adult services will be relatively more expensive but
        funding cannot be withdrawn from pediatric clinics if present good survival into adult
        life is to be maintained.</b><span style="mso-spacerun: yes">&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:
EN-GB">Hospitals
        offering centre care for CF are confronted with the financial burden of treating these
        patients. This financial burden is mostly caused by in patient expenditure. In-hospital
        cost is predominantly caused by intravenous antibiotic treatment for exacerbations of<span
        style="mso-spacerun: yes">&nbsp; </span><i style="mso-bidi-font-style:normal">Pseudomonas
        aeruginosa </i>lung infections. Additionally with increasing age, resistance becomes more
        prominent requiring newer and more expensive antibiotics.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Including
        the CF services in the general hospital medical budget leads to complaints and antagonism
        among staff when it is realised that the CF services consume a disproportionate amount of
        money. It is therefore strongly advised that the funding for CF services should be
        separately identified and provided.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-US"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman"">Because
        days in hospital account for most of the CF expenditure the most effective way to reduce
        costs is to keep patients out of the hospital.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Home
        I.V. (intravenous) therapy with antibiotics for treatment of infectious exacerbations is
        the best example. Multiple studies have shown that home I.V. antibiotic treatment is a
        viable option for selected patients who are evaluated, trained and monitored by a CF team
        experienced in home care. It may lead to a reduction in costs and is less disruptive to
        the patients and their families.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">New
        therapies may decrease the number of hospitalisations but they tend to be very expensive
        when first introduced. It is therefore important that they are properly evaluated before
        gaining general acceptance and such studies can only be undertaken by collaboration
        between CF units. Although they may eventually reduce the long-term cost of treatment they
        inevitably increase costs in the short to medium term. Cost effectiveness should be part
        of the evaluation of new therapies. Useful patient outcomes when undertaking economic
        evaluation of CF care should include pulmonary function, nutrition, quality of life and
        long term survival.<o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">It
        is recogniserd that not all patients have equally severe disease and consideration can be
        given to costing patient care according to grades of patient disease severity [11].<o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255543"></a><a
        name="_Toc494256056"></a><a name="_Toc494600638"></a><a name="9.&nbsp; Recommendations"><span
        style="mso-bookmark:_Toc494600638"><span style="mso-bookmark:_Toc494256056"><span
        style="mso-bookmark:_Toc494255543"><span lang="EN-GB"
        style="font-size:16.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB">9.<span
        style="mso-spacerun:
yes">&nbsp; </span>Recommendations</span></span></span></span></a><span
        lang="EN-GB" style="font-size:16.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB"><o:p></o:p></span></h1>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">1.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">The
        medical profession and health care providers should be educated about the requirement for
        adult cystic fibrosis services in their country. <o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">2.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">The
        distinctive medical, emotional, social and economic needs of adolescent and adult CF
        patients should be recognised.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">3.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Adult
        CF services are best provided in special, adequately staffed and funded adult- oriented
        clinics.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">4.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Where
        independent adult CF clinics cannot be justified because of insufficient numbers of
        patients, appropriate services and facilities for CF adults should be provided within the
        framework of an all-age service led by the pediatric CF clinic director.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">5.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Adult
        CF clinics should be located in large medical centres where the expertise of a
        multidisciplinary team of consultants is available.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">6.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Physicians,
        nurses, physiotherapists, dietitians and social workers providing CF care for adults
        should be given adequate training at established CF centres. Training programs for CF
        centre directors are urgently needed.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">7.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Adult
        CF patients must take the major responsibility for compliance with their health care
        programs but parents and partners should not be excluded because they have vital
        supportive roles.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">8.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Wherever
        possible, for both medical and economic reasons, care should be provided at home by CF
        team personnel, for suitable patients.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">9.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Adult
        patients should have clearly defined access and input into management policies of their
        clinic.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">10.<span
        style="font:7.0pt "Times New Roman"">&nbsp; </span>Adult CF clinics should have
        a budget clearly separated from the general budget of the hospital.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">11.<span
        style="font:7.0pt "Times New Roman"">&nbsp; </span>In the expectation that
        future drugs designed to promote a cure for CF will be expensive, the cost and benefit of
        new treatments should be rigorously evaluated.<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l20 level1 lfo56;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">12.<span
        style="font:7.0pt "Times New Roman"">&nbsp; </span>WHO, ICF(M)A and IACFA should
        keep the provision of adult CF services under review and make further recommendations if
        indicated.<o:p></o:p></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255544"></a><a
        name="_Toc494256057"></a><a name="_Toc494600639"></a><a
        name="10.&nbsp; List of participants"><span style="mso-bookmark:_Toc494600639"><span
        style="mso-bookmark:_Toc494256057"><span style="mso-bookmark:_Toc494255544"><span
        lang="EN-GB" style="font-size:16.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB">10.<span
        style="mso-spacerun: yes">&nbsp; </span>List of participants</span></span></span></span></a><span
        lang="EN-GB" style="font-size:16.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:
EN-GB"><o:p></o:p></span></h1>
        <p class="MsoNormal"><b style="mso-bidi-font-weight:normal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Dr
        P. Bye</span></b><span lang="EN-GB"
        style="font-size:
12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:
EN-GB">,
        Clinical Associate Professor, Head of Adult Cystic Fibrosis Service, Royal Prince Alfred
        Hospital, Sydney, <b style="mso-bidi-font-weight:normal">Australia<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr P. Corris,</b> Freeman Hospital,
        Newcastle-upon-Tyne, <b style="mso-bidi-font-weight:normal">UK</b><o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr A. G. Davidson, </b>Chairman, SMAC, ICF(M)A,
        Vancouver, <b style="mso-bidi-font-weight:normal">Canada<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr<span style="mso-spacerun: yes">&nbsp; </span>J. A.
        Dodge</b>, Member of a WHO Expert Advisory Panel on Human Genetics, Professor of Child
        Health, University of Wales Swansea, <b style="mso-bidi-font-weight:normal">UK (Chairman)<span
        style="mso-tab-count:
1">&nbsp;&nbsp;&nbsp;&nbsp; </span><o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr S. Elborn</b>, Consultant Physician, Belfast City
        Hospital, Belfast, <b style="mso-bidi-font-weight:normal">Northern Ireland<o:p></o:p></b></span></p>
        <p class="MsoNormal"><b style="mso-bidi-font-weight:normal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Dr
        Ilse G</span></b><b style="mso-bidi-font-weight:
normal"><span lang="FR-CH"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;
font-family:"Times New Roman";mso-ansi-language:FR-CH">ö</span></b><b
        style="mso-bidi-font-weight:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">tz</span></b><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">,
        Clinical Research Psychologist, University Children's Hospital, Vienna, <b
        style="mso-bidi-font-weight:normal">Austria<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr Manfred Götz</b>, Head, Dept. of Paediatric and
        Adolescent Medicine, Wilhelminen Hospital, Vienna, <b style="mso-bidi-font-weight:normal">Austria<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr H. Heijerman</b>, Adult Cystic Fibrosis Centre,
        Dept. of Pulmonology, Leyenburg Hospital, The Hague, <b
        style="mso-bidi-font-weight:normal">Netherlands<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr M. E. Hodson</b>, Professor of Respiratory
        Medicine, Royal Brompton &amp; Harefield NHS Trust, London, <b
        style="mso-bidi-font-weight:normal">UK<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr M. Johannesson</b>, Head, Dept. of Paediatric and
        Adolescent Medicine, Children's Hospital, Director Uppsala CF Centre, Children's Hospital,
        Uppsala University Hospital, <b style="mso-bidi-font-weight:normal">Sweden (Rapporteur)<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr G. Mastella</b>, Scientific Director, Regional
        Cystic Fibrosis Centre, Azienda Ospedaliera di Verona, <b
        style="mso-bidi-font-weight:normal">Italy<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr A.K. Webb</b>, Clinical Director of Cystic
        Fibrosis, Wythenshawe Hospital, Manchester, <b style="mso-bidi-font-weight:normal">UK</b><o:p></o:p></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr E. Widerman</b>, Assistant Professor, School of
        Social Administration, Temple University, Philadelphia, <b
        style="mso-bidi-font-weight:
normal">USA<o:p></o:p></b></span></p>
        <p class="MsoNormal"><a name="_Toc494255545"></a><a name="_Toc494256058"></a><b
        style="mso-bidi-font-weight:normal"><a name="_Toc494600640"><span
        style="mso-bookmark:_Toc494256058"><span style="mso-bookmark:_Toc494255545"><span
        lang="EN-GB"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">ICF(M)A
        Secretariat</span></span></span></a><span lang="EN-GB"
        style="font-size:14.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB"><o:p></o:p></span></b></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Ms L. Heidet</b>, ICF(M)A, <b
        style="mso-bidi-font-weight:normal">Switzerland<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Mr E. Silver</b>, ICF(M)A, <b
        style="mso-bidi-font-weight:normal">Uruguay<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Mr H. Weggen</b>, ICF(M)A, <b
        style="mso-bidi-font-weight:normal">The Netherlands<o:p></o:p></b></span></p>
        <h2><a name="_Toc494255546"></a><a name="_Toc494256059"></a><a name="_Toc494600641"></a><a
        name="_Toc494605336"><span style="mso-bookmark:
_Toc494600641"><span
        style="mso-bookmark:_Toc494256059"><span style="mso-bookmark:
_Toc494255546"><span
        lang="EN-GB"
        style="font-size:14.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">IACFA
        Secretariat</span></span></span></span></a><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><o:p></o:p></span></h2>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Ms S. Hillyard</b>, IACFA, <b
        style="mso-bidi-font-weight:normal">UK<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Ms T. Jacklin</b>, IACFA Executive Committee Member, <b
        style="mso-bidi-font-weight:normal">UK<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Mr A. Kolombos</b>, IACFA, <b
        style="mso-bidi-font-weight:normal">Israel<o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr B. Taub, IACFA</b>, <b
        style="mso-bidi-font-weight:normal">USA<o:p></o:p></b></span></p>
        <p class="MsoNormal"><a name="_Toc494255547"></a><a name="_Toc494256060"></a><b
        style="mso-bidi-font-weight:normal"><a name="_Toc494600642"><span
        style="mso-bookmark:_Toc494256060"><span style="mso-bookmark:_Toc494255547"><span
        lang="EN-GB"
        style="font-size:14.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">WHO
        Secretariat</span></span></span></a><u><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><o:p></o:p></span></u></b></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Ms G. Bellevaux</b>, WHO, Geneva, <b
        style="mso-bidi-font-weight:normal">Switzerland <o:p></o:p></b></span></p>
        <p class="MsoNormal"><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB"><b
        style="mso-bidi-font-weight:normal">Dr V. Boulyjenkov</b>, WHO, Geneva, <b
        style="mso-bidi-font-weight:normal">Switzerland <o:p></o:p></b></span></p>
        <h1 align="left" style="text-align:left"><a name="_Toc494255548"></a><a
        name="_Toc494256061"></a><a name="_Toc494600643"></a><a name="11. References"><span
        style="mso-bookmark:_Toc494600643"><span style="mso-bookmark:_Toc494256061"><span
        style="mso-bookmark:_Toc494255548"><span lang="EN-GB"
        style="font-size:16.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB">11.
        References</span></span></span></span></a><span lang="EN-GB"
        style="font-size:16.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:
EN-GB"><o:p></o:p></span></h1>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">1.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">(WHO/HPD/ICF(M)A/TF/90.4)
        <i style="mso-bidi-font-style:normal">Report of a Joint WHO/ICF(M)A Task Force on Cystic
        Fibrosis, </i>St Petersburg/Moscow 26-29 November 1990<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">2.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">(WHO/HPD/ICF(M)A/WG/92.7)
        <i style="mso-bidi-font-style:normal">Report of a Joint WHO/ICF(M)A Meeting on the
        possibilities for the Treatment of Cystic Fibrosis, </i>Washington, D.C., USA, 14 October
        1992<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">3.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span><b
        style="mso-bidi-font-weight:normal">(</b></span><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">WHO/HGN/ICF(M)A/WG/95.6<i
        style="mso-bidi-font-style:normal">) Report of a Joint WHO/ICF(M)A Meeting on:</i> <i
        style="mso-bidi-font-style:normal">Implementation of Cystic Fibrosis Services in
        Developing Countries</i><b style="mso-bidi-font-weight:normal">, </b>Manama, Bahrain,
        18-19 November 1995<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">4.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></i><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">4.Dodge
        JA, Morison S, Lewis PA, Coles EC, Geddes B, Russell G,Littlewood JM, Scott MT (The UK
        Survey Management Committee) <i style="mso-bidi-font-style:normal">Incidence, population
        and survival of cystic fibrosis in the UK, 1968-95, Archives of Disease in Childhood 1997;
        77: 493-496<o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">5.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></i><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Fitzsimmons
        SC, Cystic Fibrosis Patient Registry, <i style="mso-bidi-font-style:normal">Annual Data
        Report 1997, Bethesda, Maryland 1998<o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">6.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:
10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">Corey
        M, Canadian Cystic Fibrosis Foundation, <i style="mso-bidi-font-style:normal">Patient Data
        Registry 1996, </i>Toronto, Canada<o:p></o:p></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">7.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></i><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Frederiksen
        B, Lanng S, Koch C, Høiby N, <i style="mso-bidi-font-style:normal">Improved survival in
        the Danish centres-treated cystic fibrosis patients: results of aggressive<span
        style="mso-spacerun: yes">&nbsp; </span>treatment, Pediatric pulmonology, 1996; 21; 153-58<o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">8.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></i><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Mahadeva
        R, Webb K, Westerbeek RC, Carroll RC, Dodd ME, Bilton D, Lomas DA, <i
        style="mso-bidi-font-style:normal">Clinical outcome in relation to care in centres
        specializing in cystic fibrosis:<span style="mso-spacerun: yes">&nbsp; </span>cross-sectional
        study, British Medical Journal 1998; 316: 1771-1775<o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">9.<span
        style="font:7.0pt "Times New Roman"">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></i><span
        lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Kollberg
        H., <i style="mso-bidi-font-style:normal">Incidence and survival curves of cystic fibrosis
        in Sweden, Acta Paediatr Scand 1983; 72: 427-432<o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-size:12.0pt;
mso-bidi-font-size:10.0pt;font-family:"Times New Roman";mso-ansi-language:EN-GB">10.<span
        style="font:7.0pt "Times New Roman"">&nbsp; </span></span></i><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Corey
        M, McLaughlin FH, Williams M, Levison H, <i style="mso-bidi-font-style:normal">A
        comparison of survival, growth and pulmonary function in patients with cystic fibrosis in
        Boston and Toronto. J Clin, Epidemiol 1988; 41: 583-91<o:p></o:p></i></span></p>
        <p class="MsoNormal"
        style="margin-left:18.0pt;text-indent:-18.0pt;mso-list:l33 level1 lfo57;
tab-stops:-72.0pt -36.0pt list 18.0pt"><i
        style="mso-bidi-font-style:normal"><span lang="EN-GB"
        style="font-family:"Times New Roman";
mso-ansi-language:EN-GB">11.<span
        style="font:7.0pt "Times New Roman"">&nbsp; </span></span></i><span lang="EN-GB"
        style="font-size:12.0pt;mso-bidi-font-size:10.0pt;font-family:"Times New Roman";
mso-ansi-language:EN-GB">Robson
        M, Abbot J, Webb K, Dodd M, Walsworth-Bell J, <i style="mso-bidi-font-style:normal">A cost
        description of an adult cystic fibrosis unit and cost analyses of different</i></span><i
        style="mso-bidi-font-style:
normal"><span lang="EN-GB"
        style="font-family:"Times New Roman";mso-ansi-language:
EN-GB"> categories of
        patient. Thorax 1992; 47:684-689.<o:p></o:p></span></i></td>
      </tr>
</TBODY>
      <tr>
        <td colSpan="2" vAlign="top" width="654" height="0"><hr>
        <h5 align="center">| <a href="/">WHO Home</a> |<br>
        | <a href="../asthma/index.htm">Asthma</a> | <a href="../cancer/index.htm">Cancer</a> | <a
        href="../cvd/index.htm">Cardiovascular diseases</a> | <a href="../dia/index.htm">Diabetes</a>
        | <a href="index.htm">Human genetics</a> | <a href="../orh/index.htm">Oral health</a> | <a
        href="http://www5.who.int/tobacco/">Tobacco use</a> | <a href="../noma/index.htm">Noma</a>
        |<br>
        </h5>
        <h5 align="left"><font size="2">Contact us: <a href="mailto:ncdinfo@who.int">ncdinfo@who.int</a>
        .<br>
        Copyright </font><font size="1"><a class="Asmall"
        href="/home/copyright/index.en.html">© WHO/OMS, 2001</a> </font></h5>
        </td>
      </tr>
    </table>
    </center></div></td>
  </tr>
</TBODY>
</table>
<p>&nbsp;</p>
</body>
</html>

